Evaluating the Efficacy of Oral Ivermectin on Clinical Symptoms and Demodex Densities in Patients with Demodicosis
Anon Paichitrojjana,Thep Chalermchai
DOI: https://doi.org/10.2147/dddt.s498938
IF: 4.3188
2024-11-27
Drug Design Development and Therapy
Abstract:Anon Paichitrojjana, Thep Chalermchai School of Anti-Aging and Regenerative Medicine, Mae Fah Luang University, Bangkok, Thailand Correspondence: Thep Chalermchai, School of Anti-Aging and Regenerative Medicine, Mae Fah Luang University, Khlong Toei Nuea, Watthana, Bangkok, 10110, Thailand, Email Background: Dermatologists consistently face challenges in treating demodicosis due to its high recurrence rate and difficulty normalizing the Demodex density (Dd) even after clinical improvement. Oral ivermectin has proven to be an effective treatment for demodicosis. However, there is a lack of comprehensive information on the clinical and acaricidal effects of oral ivermectin in treating demodicosis. Purpose: This study aims to evaluate the effectiveness of oral ivermectin on clinical symptoms and Dds of patients with demodicosis. Methods: This prospective, quasi-experimental study included 40 demodicosis patients (20 with Demodex densities (Dds) < 20 D/cm 2 , 20 with Dds ≥ 20 D/cm 2 ). Both groups of patients were treated with oral ivermectin (200 μg/kg/week) until excellent clinical improvement (Grade 4 according to the Quartile Grading Scale), and Dds ≤ 5 D/cm 2 or treated with oral ivermectin for a total of eight weeks period. Results: In our study, 75% of patients achieved clinical remission, showing excellent clinical improvement with Dds ≤ 5 D/cm 2 . All patients with a Dds < 20 D/cm2 experienced remission, while 50% with a Dds ≥ 20 D/cm2 achieved remission. The median time to remission after oral ivermectin treatment was 28 days for Dds < 20 D/cm2 and 56 days for Dds ≥ 20 D/cm2 (p < 0.001). Conclusion: Oral ivermectin effectively improves clinical symptoms and normalizes Dds in patients with demodicosis. Patients with higher Dds require a longer treatment than those with lower Dds. Keywords: ivermectin, demodicosis, Rosacea, Demodex mite, Demodex folliculorum , Demodex brevis Demodex mites are ectoparasites that live in the pilosebaceous units of human skin and are part of the natural skin microflora. The normal Demodex density (Dd) on the face in the adult population is ≤ 5/cm 2 . 1 Excessive Demodex mites on the face can cause demodicosis, leading to symptoms such as dryness, itching, burning, scaly patches, papules, pustules, and telangiectasia. 2–4 This overgrowth is also related to a range of skin disorders, such as rosacea, 5,6 blepharitis, 7 perioral dermatitis, 8 pityriasis folliculorum, 9 and pustular folliculitis. 10 Common treatments for demodicosis include topical ivermectin, benzyl benzoate, tea tree oil, metronidazole, permethrin, crotamiton, lindane, and oral medication such as ivermectin or metronidazole, or a combination of these. 11–13 Oral ivermectin has been cited as an effective treatment for demodicosis in humans, 12,14–16 and dogs, 17,18 as well as for rosacea associated with Demodex mite infestation. 19–22 Nevertheless, no study has been conducted to assess its effectiveness in treating human demodicosis. This study aims to evaluate the effectiveness of oral ivermectin on clinical symptoms and Dds of patients with demodicosis. This study encompassed 40 patients aged 18 to 45 who visited our clinic and were diagnosed with demodicosis. We secured Ethics Committee approval, and all participants provided informed consent. All patients underwent a thorough medical history and a skin examination by a dermatologist. The diagnosis of demodicosis is based on the clinical presentation and demonstrating the presence of live Demodex mites ≥ 5/cm2. 5 All patients were divided into two groups of 20 based on their detected Dds. One group with Dds < 20 D/cm 2 , while the other had Dds ≥ 20 D/cm 2 . During the initial consultation and follow-up appointments, each patient underwent a Standardized Skin Surface Biopsy (SSSB) on both cheeks. The procedure started by cleaning the sampling area with mild liquid soap and the glass slides with 70% alcohol. The sampling sites were consistently chosen at the same location from the skin lesions on both cheeks. For the SSSB, a 1 cm 2 square marked slide coated with cyanoacrylate glue was placed on each cheek for 1 minute before gently removing it. Subsequently, immersion oil was applied to the slide, which was then covered with a cover slip for microscopic examination. To calculate Dd, the alive larvae, nymphs, or adults of D. folliculorum or D. brevis within a 1 cm 2 marked area from each cheek was counted and averaged from the sum -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal